
Asia-Pacific tech monitor. Vol. 29, No. 3, Jul - Sep 2012
Loading...
View/Open
Date
2012
Contributor/s
Corporate Author/s
Contact
Citation
Country/Region
Series
Vol. 29, No. 3, Jul - Sep 2012
Area(s) of Work
UN SDG
UNBIST Subject
Abstract
Biotechnology sector in the Asia-Pacific region has seen remarkable
and rapid growth in the recent years due to policy push by governments
and technological breakthroughs. According to a new research
report by the international industry research and consultancy firm
RNCOS, entitled ‘Asia-Pacific Biotechnology Market (2008–2012)’, the
Asia-Pacific biotech market is projected to grow at a compound annual
growth rate (CAGR) of around 19% during 2010–2013. The research has
also found that at the regional forefront, Japan and China are dominating
this industry, while higher growth rates have been witnessed
in emerging markets, such as Malaysia and India.
The biotechnology industry is cross-disciplinary and broadly encompasses areas such as pharmaceuticals,
diagnostics, food, agriculture and environmental applications in the fields of bioremediation
and waste treatment. The industry could be fostered and promoted with a conducive
government policy environment, linkages with robust R&D institutes, protection of intellectual
property rights, and opportunities for commercialization of research outputs. In this context, it
is important to note that biotech innovations have to go through with the value chain of basic
research, applied research, lab-scale and prototype development, clinical trials, verification and
validation, production/manufacturing, marketing and post-marketing services. The biotechnology
value chain, like other technology domains is becoming more complex due to globalization
of various components of the value chain.
Citation
Collections
PDF Viewer
Select a file to preview:
Can't see the file? Try refreshing your browser

